About T&L
T&L is a company based in Yongin (South Korea) founded in 1998. The company has 220 employees as of December 31, 2024. T&L offers products and services including Medical Products and Chemical Products. T&L operates in a competitive market with competitors including Adhezion Biomedical, HyperBranch Medical, BRIJ Medical, BORAYER and Inno Therapy, among others.
- Headquarter Yongin, South Korea
- Employees 220 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name T&L Co. Ltd.
-
Annual Revenue
$118.58 M (USD)51.47as on Dec 31, 2024
-
Net Profit
$31.47 M (USD)69.13as on Dec 31, 2024
-
EBITDA
$41.26 M (USD)80.93as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
220
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of T&L
T&L is a publicly listed company on the KRX with ticker symbol 340570 in South Korea, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of T&L
T&L offers a comprehensive portfolio of products and services, including Medical Products and Chemical Products.
Products for safe wound and fracture treatment applications.
Additives for paint, textiles, and industrial processes.
Funding Insights of T&L
Detailed funding history for TL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by T&L
Investment portfolio details for TL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TL
Detailed financials for TL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
T&L Comparisons
Peer comparison for TL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of T&L
T&L operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, HyperBranch Medical, BRIJ Medical, BORAYER and Inno Therapy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
|
|
| Locked | Locked | Locked |
Biosurgical devices are developed using proprietary polymers and hydrogels.
|
|
| Locked | Locked | Locked |
Medical devices for post-surgical and trauma incision care are provided.
|
|
| Locked | Locked | Locked |
Biomaterials for surgery and wound repair are developed.
|
|
| Locked | Locked | Locked |
Hemostatic polymers are produced for surgical and wound care applications.
|
|
| Locked | Locked | Locked |
Adhesive solutions are manufactured for diverse materials and applications.
|
Detailed competitors of TL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on T&L
Complete news archive for TL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about T&L
T&L was founded in 1998.
T&L is headquartered in Yongin, South Korea. It is registered at Yongin, Gyeonggi, South Korea.
As of Dec 31, 2024, the latest employee count at T&L is 220.
Annual revenue of T&L is $118.58M as on Dec 31, 2024.
TL Co. was founded in 1998 in South Korea. High-molecule technological products are developed for the orthopedic and wound care sectors. Orthopedic offerings include casts, flex materials, elasticast, splints, finger splints, ever fresh padding, and thunder braces. Wound care items encompass hydro-colloid dressings, Renofoam variants (non-adhesive and self-adhesive), hydrogel dressings, and perforated silicone foams. Operations center on polymer-based materials for these medical applications.
T&L's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.
T&L offers Medical Products and Chemical Products.
Yes, T&L is publicly traded on KRX under the ticker symbol 340570.
The ticker symbol of T&L is 340570 on KRX.